Back to search

Oz-Uk Limited

09692255

active
Private Limited Company
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Current liabilities exceed current assets (-10)

Details

UNIT 15A LANSDOWNE COURT, CHIPPENHAM, SN14 6RZ
Incorporated 17/07/2015

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Mr Robert David Johnson

director · Since 17/07/2015

PHARMACEUTICAL DEVELOPMENT

BRITISH · ENGLAND · Age 47

Dr David Andrew Lewis Bsc Msc Phd

director · Since 17/07/2015

PHARMACEUTICAL DEVELOPMENT

BRITISH · ENGLAND · Age 58

Also on 3 other boards

Doctor Paul Michael Young

director · Since 17/07/2015

PHARMACEUTICAL DEVELOPMENT

BRITISH · AUSTRALIA · Age 51

Persons with Significant Control

Dr David Andrew Lewis

25–50% shares
25–50% votes

British · England · Age 58

Unit 15a Lansdowne Court, Bumpers Way, Chippenham, SN14 6RZ

Notified 17/07/2016

Doctor Paul Michael Young

25–50% shares
25–50% votes

British · Australia · Age 51

Unit 15a Lansdowne Court, Bumpers Way, Chippenham, SN14 6RZ

Notified 20/02/2023

Mr Robert David Johnson

25–50% shares
25–50% votes

British · United Kingdom · Age 47

Unit 15a Lansdowne Court, Bumpers Way, Chippenham, SN14 6RZ

Notified 20/02/2023

CompanyRankvs 1213+ SIC 72110 peers
58

Financial strength35th percentile among SIC peers · 9/25
Employees22th percentile among SIC peers · 3/15
LiquidityCurrent ratio 3.96× · 20/20
Longevity11 years trading (max 15) · 11/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Bio - Diagnostics Limited
89
9Biointeractions Limited
89
10Ams Advanced Medical Services Limited
89
1213Oz-Uk Limited
57
How is this score calculated?
Financial strength9/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees3/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity11/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/07/2025

Net Worth

£3

Balance sheet strength

Cash

£96k

Cash in the bank

Net Current Assets

£150k

Working capital

Current Assets

£201k

Current Liabilities

£51k

Fixed Assets

£282k

Debtors

£105k

0avg. employees-8

Tax at Year End(2023)

Corp tax£0

Balance Sheet

Assets less current liabilities£432k
Prepared with CCH Software

EstimatesDerived

YearCurrent RatioImplied Profit
20253.96—
20242.14+£162k
20237.34-£173k
20225.26+£402k
20214.29+£48k
20203.86+£54k
20192.72-£2k
20182.07—

Derived from filed accounts. Not audited figures.